Kalpatantra now operates through a dual structure inspired by Sāṅkhya and Yoga: • Vaidya Gurukula — the research and knowledge think tank • Kalpatantra Pvt. Ltd. — the engineering and execution engine Together they focus on building infrastructure across four innovation domains: • Medicine & Food Innovation • IoT & Electronic Systems for Ayurveda • Mechanical & Robotics Engineering • Software & Digital Knowledge Platforms

In 2025, research and educational initiatives that had been running informally under the Vaidyagurukulam initiative were formally structured as a Section 8 organization. Kalpatantra Vaidya Gurukula & Research Foundation The Gurukula serves as the research think tank responsible for classical studies, clinical research, and knowledge development.

During the development of digital platforms, it became clear that many practitioners prefer traditional writing methods. To bridge this gap, Kalpatantra began exploring smart pen and book systems capable of converting handwritten notes into structured digital text, enabling a smooth transition between analog and digital workflows.

While exploring ways to digitize classical texts and practitioner knowledge, the concept of Vaikhari emerged. Vaikhari is envisioned as an AI-enabled platform combining: • digital Samhita access • authoring and editing tools • peer knowledge sharing • structured Sanskrit–Ayurveda knowledge systems This initiative focuses on transforming textual knowledge into deployable intelligence.

Observations across clinics revealed a major lack of digitization in Ayurvedic practice. To address this gap, Kalpatantra began developing OPDO, a clinical digitization platform designed to convert traditional practice into structured digital records while remaining accessible to practitioners. OPDO was designed as a free entry platform with advanced operational modules available as specialized services.

Research also led to the design of a four-tier medicine framework to preserve different knowledge streams in Ayurveda: • Classical medicines • Proprietary formulations • Traditional medicines preserved through lineage practice • Doctors’ Diary formulations — clinical medicines developed by practitioners during research or long-term practice This model aimed to preserve valuable therapeutic knowledge that often disappears when doctors retire or research remains unpublished.

In order to ensure large-scale production without compromising authenticity, Kalpatantra entered into an agreement with Shri Atharva Ayurveda Rasayana Shala. This collaboration enabled the production of medicines aligned with classical references and strict quality verification. Market analysis during this period revealed a major demand–authenticity gap despite the presence of hundreds of manufacturers.

A broader market study was conducted to understand why Ayurveda was losing its clinical authority despite increasing government and public support. The analysis revealed a structural shift: Ayurveda was gradually moving away from clinical medicine toward wellness and spa-driven services, often reducing therapeutic depth. This observation led to exploring models that could restore department-based clinical systems within Ayurveda practice.

One of the most significant findings during clinical observation was the absence of structured Nadī-Śāstra practice in modern Ayurveda clinics. A focused study was conducted to understand: • why Nadī diagnosis disappeared from mainstream training • challenges in preserving diagnostic traditions • possibilities of engineering support tools for measurable diagnostic systems This research eventually led to the conceptual planning of a Nadī diagnostic device.

Alongside research, Kalpatantra began observing real-world clinical practice by serving patients in clinics. This phase focused on understanding: • treatment continuity • practitioner workflow challenges • diagnostic gaps • patient outcome variability The objective was to observe how Ayurveda functions on the ground rather than only in theory.

Following the foundational assessment, structured field studies were conducted to understand the authenticity gap in herbal sourcing. Research focused particularly on two sensitive categories: • Kashmir Saffron (GI Tag) — studying origin integrity, bulb lineage, and substitution patterns in the market. • Shilajit Authentication — analyzing classical references alongside laboratory verification to understand purity standards and commercial distortions. These studies formed the basis for introducing authenticated materials aligned with classical Ayurvedic expectations.

Kalpatantra was established with the conviction that Ayurveda’s challenge was not popularity but infrastructure. The first phase focused on ground assessment—studying supply chains, clinical practices, diagnostic traditions, and operational gaps within the Ayurveda ecosystem. Initial research identified key missing layers such as raw material traceability, diagnostic continuity, clinical workflow systems, and deployable knowledge infrastructure.